Section Navigation
Section Navigation
- Module 8 Overview
HCV Test and Cure - 0%Lesson 1
Epidemiology and Natural HistoryActivities- 0%Lesson 2
Screening, Diagnosis, and PreventionActivities- 2A.Core Concepts
- 2B.Interpretation of HCV Diagnostic Laboratory Test Results
- 2C.Strategies for Implementing Hepatitis C Virus Point-of-Care Testing
- 0%Lesson 3
Pretreatment Evaluation and Fibrosis StagingActivities- 3A.Core Concepts
- 3B.FibroScan: A Clinician's Guide
- 3C.Calculating FIB-4 Score
- 3D.Calculating a CTP Score
- 0%Lesson 4
HCV Simplified TreatmentActivities- 4A.Core Concepts
- 4B.HCV Point of Care Testing and the Test and Treat Approach
- 4C.Simplified Treatment Criteria
- 4D.Recommended Regimens for Simplified Treatment Approach
- 4E.Follow up After the HCV Test and Treat Approach
- 4F.Initiation of HCV Treatment in Person with Alcohol Use Disorder
- 4G.Glecaprevir-Pibrentasvir Treatment with Compensated Cirrhosis
- 4H.Sofosbuvir-Velapatasvir Treatment with Compensated Cirrhosis
- 4I.Drug Interactions with Glecaprevir-Pibrentasvir
- 4J.Drug Interactions with Sofosbuvir-Velpatasvir
- 4K.Management of Treatment Interruption with less than 7 Missed Days
- 4L.Management of Treatment Interruption After Missing 8-20 Days
- 0%Lesson 5
Follow-Up and Promoting Liver HealthActivity 5C. How to Use Liver Tox
Learning Objective Performance Indicators
- Perform follow-up monitoring of persons after treatment for chronic HCV
- Obtain an HCV RNA assay as appropriate to screen for HCV reinfection after a person clears HCV
- Administer priority immunizations for people with chronic HCV
- Engage a person with chronic or cleared HCV in a discussion about measures that promote liver health
- Institute routine screening for hepatocellular carcinoma and varices for persons with cirrhosis
Instructions: Read the case history, then use the LiverTox link and read the brief summary on St. John's Wort, with a particular focus on the liver toxicity section.
Background
A 57-year-old woman presents to your clinic for a routine follow-up appointment. She has a history of anxiety, depression, and chronic hepatitis C virus (HCV). She recently started taking St. John’s Wort for her anxiety and depression and has been seeing a therapist. She is getting ready to start on treatment for HCV, and she asks you if St. John’s Wort is safe for her liver.Activity Question
You should answer this question after completing the activity.You must answer all of the questions before checking your work.
This activity has a Check on Learning question. - Show QuestionWhich one of the following best describes St. John’s Wort in relation to potential hepatoxicity and drug interactions?
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-monorepo-75ec26d4-2025-04-30-205728
Become a New User
Account Registration Benefits:
- Track your progress on the lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started